Search results for "Infectious Diseases"
CDC study shows uptick in C. auris infections in recent years
Cases and transmission of Candida auris have continued to rise since the multidrug-resistant fungus was first reported in the U.S. in 2016. Reports of cases to the CDC rose by 44% in 2019 and 95% in 2021.
https://immattersacp.org/weekly/archives/2023/03/21/1.htm
21 Mar 2023
New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised
One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://immattersacp.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
ATS/IDSA release clinical practice guideline on diagnosing, treating CAP
The new American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guideline updates the 2007 community-acquired pneumonia (CAP) guideline, and changes include a different perspective on macrolides.
https://immattersacp.org/weekly/archives/2019/10/08/4.htm
8 Oct 2019
Answers and even more questions on COVID-19 vaccines
In a fourth forum from ACP and Annals of Internal Medicine, infectious disease experts Carlos del Rio, MD, FACP, Paul Sax, MD, and Deborah Cotton, MD, MPH, FACP, discussed COVID-19 vaccines and their implementation, as well as other aspects of the pandemic response.
https://immattersacp.org/weekly/archives/2021/03/30/2.htm
30 Mar 2021
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020
Clinician education, feedback led to fewer inappropriate antibiotics for respiratory tract infections
A stepped-wedge cluster randomized study in 31 primary care practices found that the proportion of visits with an antibiotic prescription decreased from 35.2% to 23.0% after an intervention involving clinician education and monthly peer comparison feedback.
https://immattersacp.org/weekly/archives/2021/07/13/5.htm
13 Jul 2021
Internal Medicine Meeting 2021: Virtual Experience to feature three plenary speakers, including Dr. Anthony Fauci
Join ACP for internal medicine's most comprehensive educational program in a new, engaging, interactive, and virtual format.
https://immattersacp.org/weekly/archives/2021/02/23/6.htm
23 Feb 2021
Screening, treatment of asymptomatic bacteriuria not needed for most, guideline states
The Infectious Diseases Society of America recommends screening and treatment only in pregnant women and in patients undergoing endoscopic urologic procedures associated with mucosal trauma.
https://immattersacp.org/weekly/archives/2019/03/26/2.htm
26 Mar 2019
IDSA updates treatment guidelines, while studies identify symptoms in specific age groups
The Infectious Diseases Society of America (IDSA) changed its recommendations on steroids, remdesivir, and other therapies. New research from Europe quantified COVID-19 symptoms in older adults as well as neurological complications.
https://immattersacp.org/weekly/archives/2020/06/30/1.htm
30 Jun 2020